Status:
RECRUITING
Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort
Lead Sponsor:
Semmelweis University
Conditions:
Infertility, Female
Polycystic Ovary Syndrome
Eligibility:
FEMALE
20-45 years
Brief Summary
Enrolling of 150 female patients of fertile age diagnosed with PCOS, insulin resistance, infertility, or mitochondrial disease, and the same number of age- and sex-matched controls are planned. Durin...
Detailed Description
Mitochondrial dysfunction can be involved in the development of clinically heterogeneous diseases affecting multiple tissues and organs and can manifest at any age. Clinical signs are mainly manifeste...
Eligibility Criteria
Inclusion
- Presence of polycystic ovary syndrome (PCOS) or insulin resistance (IR) associated with other multisystemic phenotypes, mitochondrial dysfunction
- history of infertility associated with other multisystemic phenotypes, mitochondrial dysfunction
- a known history of mitochondrial dysfunction and PCOS and/or IR
- general health is good and there is no serious general medical condition that would prevent participation would make participation highly risky
Exclusion
- poor cooperation
- refusal to participate in the study
Key Trial Info
Start Date :
September 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2033
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06167135
Start Date
September 10 2021
End Date
September 30 2033
Last Update
December 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Semmelweis University
Budapest, Hungary, 1082